About
This HIPAA-compliant app connects clinicians with clients for substance use disorder treatment. It offers secure communication, in-person, and telemedicine visits to improve treatment access and effectiveness in a private setting.
What's New in Aspire
1.0
February 26, 2021
Developer apps
FAQ
What is Aspire-365 Patient Connect?
Aspire-365 Patient Connect is a HIPAA-compliant application designed to facilitate secure communication between clinicians and clients for substance use disorder treatment. It supports both in-person and telemedicine visits to enhance treatment accessibility and effectiveness.
Is Aspire-365 Patient Connect free to use?
Yes, Aspire-365 Patient Connect is available for free. There are no in-app purchases or subscription fees associated with using the application.
What devices does Aspire-365 Patient Connect support?
Aspire-365 Patient Connect is compatible with iPhone, iPad, and iPod devices. It is designed for use on Apple's iOS platform.
How does Aspire-365 Patient Connect ensure client privacy?
The application is fully HIPAA and PCI compliant, ensuring that all client data and communications are handled with the highest level of security and privacy. It utilizes secure video and audio quality for all interactions.
What kind of support does Aspire-365 Patient Connect offer?
Clients and their families receive 24-hour support through the Aspire365 communication platform. This includes support from their dedicated Recovery Support Team (RST) and family therapists.
When was Aspire-365 Patient Connect last updated?
Aspire-365 Patient Connect was last updated on February 26, 2021, coinciding with its initial release date. The current version is 1.0.
What is the age rating for Aspire-365 Patient Connect?
Aspire-365 Patient Connect has an age rating of 12+. This indicates it is suitable for users aged 12 and older.
Does Aspire-365 Patient Connect have ads?
No, Aspire-365 Patient Connect does not contain advertisements. The application is ad-free, allowing for an uninterrupted user experience.
